Clinical Trial Update: Daclizumab Experience in Pediatric Heart Transplant

View source ↗

Summary

The document provides a clinical trial update on the use of daclizumab in pediatric heart transplant patients and notes that the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease

Drugs mentioned

• Zenapax (daclizumab)

Snippet

Sponsor: Children's Healthcare of Atlanta | Conditions: Congenital Disorders | Status: TERMINATED